Page last updated: 2024-12-08

dansylethylenediamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID161851
CHEMBL ID1766567
SCHEMBL ID1293231
MeSH IDM0101091

Synonyms (29)

Synonym
35060-08-3
CHEMBL1766567
n-(2-aminoethyl)-5-(dimethylamino)-1-naphthalenesulfonamide
n-(2-aminoethyl)-5-(dimethylamino)naphthalene-1-sulfonamide
NCI60_023306
sjl 620
scp-29178 2b
nsc666752
nsc-666752
dansylethylenediamine
monodansylethylenediamine
dansyl ethylenediamine
SCHEMBL1293231
1-naphthalenesulfonamide, n-(2-aminoethyl)-5-(dimethylamino)-
dns-eeda
AKOS015915994
(2-aminoethyl)dansylamide
FT-0620361
(2-aminoethyl)-dansylamide
5-dimethylamino-naphthalene-1-sulfonic acid (2-amino-ethyl)-amide
n-dansyl-ethylenediamine
CSJXLKVNKAXFSI-UHFFFAOYSA-N
DTXSID70188566
n-dansylethylenediamine, suitable for fluorescence
J-019848
n-dansylethylenediamine
mfcd00467523
CS-0362066
HY-W321446
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID593051Antiproliferative activity against human MCF7 cells expressing estrogen receptor after 48 hrs by WST-1 assay2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
Fluorescent cyclin-dependent kinase inhibitors block the proliferation of human breast cancer cells.
AID593053Antiproliferative activity against estrogen receptor-deficient human MDA-MB-231 cells after 48 hrs by WST-1 assay2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
Fluorescent cyclin-dependent kinase inhibitors block the proliferation of human breast cancer cells.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (18.18)18.7374
1990's5 (45.45)18.2507
2000's1 (9.09)29.6817
2010's3 (27.27)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.51 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.99 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]